Chemo Spain – Leandro Sigman, General Manager
Leandro Sigman, general manager of Chemo, discusses changes in the Spanish market and the company’s strategy to target international markets. The crisis has changed the way companies operate in…
Established over 35 years ago, Chemo operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, both for human and animal health.
While the main offices are located in Madrid, Lugano and Buenos Aires, Chemo is acting worldwide, creating a broad and balanced manufacturing and commercial network across major pharmaceutical markets in Europe, America, Asia and Africa, to address global opportunities and customers` needs.
Chemo`s activity is organized in three synergistic business areas: industrial, branded and biotech, with over 5,000 professionals in more than 40 countries, across four continents, ten state-of-the-art manufacturing facilities, nine specialized R&D centers, 12 commercial offices and 33 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world.
Chemo believes in innovation and sustainable development. The company’s commitment is to improve people`s health and quality of life, providing access to safe, quality and affordable medicines, and to continuously expand its efforts and R&D investment to develop new and better therapies.
Contact details:
Chemo Barcelona
Gran Vía Carlos III, 98 7th floor
08028 Barcelona , Spain.
Tel: + 34 93 330 62 12
Fax: + 34 93 330 27 62
BarcelonaChemo@chemogroup.com
Leandro Sigman, general manager of Chemo, discusses changes in the Spanish market and the company’s strategy to target international markets. The crisis has changed the way companies operate in…
Esteve’s presence in Spain dates back to 1929, and has been a privileged witness to the evolution of modern Spain. In more recent times, the country’s crisis has changed the…
“We have to be optimistic, but we also need to plan much better for the future with regard to health authorities and medical education. I believe that industry in Spain…
“We have to be optimistic, but we also need to plan much better for the future with regard to health authorities and medical education. I believe that industry in Spain…
After serving as President of Lilly Spain between 2001 and 2009, Javier Ellena spent three years running Lilly’s middle-sized European markets (EMS). In 2012, he returned to his previous role…
After serving as President of Lilly Spain between 2001 and 2009, Javier Ellena spent three years running Lilly’s middle-sized European markets (EMS). In 2012, he returned to his previous role…
“While the last five years of economic struggle and brain drain have been some of the most calamitous times for the country, I maintain a strong sense of optimism. Spain…
Spain’s pharmaceutical industry has been subject to numerous austerity measures over the past few years as a consequence of the country’s recession. Humberto Arnés, director general of Spain’s research-based pharmaceutical…
The Spanish pharmaceutical industry has been affected by a number of austerity measures in recent years, and companies selling generics in Spain have encountered various challenges and opportunities as a…
See our Cookie Privacy Policy Here
